Compare CVS Health Corp (CVS) vs iShares Semiconductor ETF (SOXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs iShares Semiconductor ETF — how do they compare? CVS Health Corp trades at $86.25 (market cap $112.29B), while iShares Semiconductor ETF trades at $572.16 (market cap $48.19B). The key difference: CVS Health Corp is far larger — about 2.3× iShares Semiconductor ETF's market cap, and CVS Health Corp pays a 3.03% dividend while iShares Semiconductor ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and iShares Semiconductor ETF for 46 Days on average.
| CVS | SOXX | |
|---|---|---|
Market Cap | $112.29B | $48.19B |
Volume | 7,763,676 | 10,257,578 |
Sector | Health | Sector/Thematic |
52-Week High | $110.60 | $655.01 |
52-Week Low | $70.08 | $268.10 |
Typical Hold Time | 83 Days | 46 Days |
Enterprise Value | $174.64B | — |
Dividend Yield | 3.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
SOXX trades at $582.94, down 1.1% today but maintains a bullish technical stance with strong moving average support. The semiconductor ETF benefits from AI-driven demand, with recent news highlighting sector gains and positive earnings momentum. However, high valuations and Michael Burry's expanded short position signal caution amid the AI boom.
Outlook remains positive due to structural AI growth, but risks include valuation concerns and sector concentration. Earnings growth supports further upside, though macroeconomic conditions and competitive pressures could temper returns. Investors should balance optimism with prudent risk management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About iShares Semiconductor ETF
SOXX provides investors with exposure to U.S. companies that design, manufacture, and distribute semiconductors. It tracks the ICE Semiconductor Index, offering a targeted investment in the technology sector's foundational components, including firms that produce chips, related equipment, and services. SOXX is a key vehicle for investors seeking to capitalize on trends in artificial intelligence, 5G, and other technologies that rely heavily on advanced semiconductor technology.
Read more on SOXX →
